Allergan confident on Botox

Allergan, the global pharmaceutical company that makes Botox and breast implants, has forecast nearly £1bn in Botox sales this year, and said the company continues to be robust in the US despite a sluggish economy. Botox, most commonly used to smooth wrinkles, has recently acquired US approval to treat migraine headaches and overactive bladders, positioning it to grow beyond the 30 per cent of Allergan sales it accounts for now. The company is also increasing its investment in Asia to take advantage of growing demand for its products, with revenues in Asia up 36 per cent from a year ago in its latest quarter.